LONDON, September 18, 2017 /PRNewswire/ --
Revenue Prospects by Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies
POC Diagnostics - our new study reveals trends, R&D progress, and predicted revenues:
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
Where is the POC Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead:
Our 289-page report provides 161 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing POC Diagnostics market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects:
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets:
Along with revenue prediction for the overall world market, there are forecasts for 7 POC Diagnostics Types, each forecasted at a global level.
POC Diagnostics, by Product Type:
• Blood Glucose
• Infectious Diseases
• Rapid Coagulation
• Rapid Cardiac Marker
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 15 leading national markets:
• The US
• The UK
• The Netherlands
• South Africa
The report also includes profiles and for some of the leading companies in the POC Diagnostics market, with a focus on this segment of these companies' operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Japan in particular, will continue to achieve high revenue growth to 2027.
Leading companies and the potential for market growth:
Overall world revenue for POC Diagnostics will surpass $5bn in 2027, our work calculates. We predict strong revenue growth through to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the POC Diagnostics Market report helps you:
In summary, our 289-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the POC Diagnostics market with forecasts for 7 Types of POC testing - discover the industry's prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 15 key national markets - See forecasts for the POC Diagnostic market in the US, Japan, Germany, France, the UK, Italy, Spain, Belgium, The Netherlands, Switzerland, Brazil, China, India, South Africa and Russia
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market - including company profiles for 4 of the major companies involved in the POC Diagnostics market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else:
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain's study is for everybody needing commercial analyses for the POC Diagnostics market and leading companies. You will find data, trends and predictions.
Get our report today POC Diagnostic Systems Market Forecast 2017-2027: Analysis of POC Diagnostics Market Forecast 2017-2027: Revenue Prospects by Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies.
To request a report overview of this report please email Sara Peerun at firstname.lastname@example.org or call Tel: +44-(0)-20-7336-6100
Companies Mentioned in the Report
Abbott Cardiovascular Inc
Abbott Diabetes Care
Abbott Molecular Inc.
Abbott Point of Care
Alere Health Systems Inc.
Alere Medical Japan
Amgenix International Inc
Ascensia Diabetes Care
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd
Chembio Diagnostic Systems
Church & Dwight
Clinical Micro Sensors, Inc.
Dako Denmark A/S
DakoCytomation Denmark A/S
Decision Diagnostics Corp.
Diabetic Supply of Suncoast
Early Pregnancy Tests.com
Entra Helath Systems
Exact Sciences Corporation
General Life Biotechnology Ltd
Genesis Health Technology
Home Access Health Corporation
IND Diagnostic Inc.
Instrumentation Laboratory (a company of Werfen Group)
Integrity Applications Ltd.
International Technidyne Corporation
Iris Molecular Diagnostics
JANT Pharmacal Corporation
Johnson & Johnson
Luminex Molecular Diagnostics, Inc.
Marnes La Coquette
Maxim Biomedical Inc
MIZUHO MEDY Company
Myriad Genetic Laboratories, Inc.
Oak Tree Health
Oak Tree International Holdings
Ortho-Clinical Diagnostics, Inc.
Osmetech Molecular Diagnostics
Pathwork Diagnostics Inc.
Pharma Tech Solutions
POC Medical System
Polymer Technology Systems Inc
Premier Medical Corporation
Procter & Gamble
Prodigy Diabetes Care
Response Biomedical Corporation
Roche Diagnostics Corporation
Roche Molecular Systems, Inc.
RunBio Biotech Company
Sedia Biosciences Corporation, USA
Sekisui Medical Company
Shanghai Kehua Bioengineering Co., Ltd.
Siemens Financial Services GmbH
Siemens Healthcare Diagnostics GmbH
Siemens Healthcare Diagnostics SA
Siemens Healthcare EOOD
Spartan Bioscience, Inc.
Standard Diagnostics Inc.
Swiss Precision Diagnostics
Thermo Fisher Scientific
Third Wave Technologies Inc.
Tm Bioscience Corporation
Ventana Medical Systems, Inc.
To see a report overview please email Sara Peerun on email@example.com
SOURCE Visiongain Ltd